India, July 13 -- Autonomix Medical, Inc. (AMIX) shares fell 11.05 percent to $5.83 on Monday, despite the company announcing the grant of a new Canadian patent that expands its intellectual property portfolio for precision nerve-targeted therapies.
The stock opened at $5.86 after closing at $6.57 in the previous session on the Nasdaq. It traded between $5.54 and $6.05 during the session, while about 2.43 million shares changed hands, compared with an average daily volume of 0.04 million shares.
The patent, titled "Endoscopic Sympathectomy Systems and Methods," strengthens Autonomix's global IP portfolio to 112 issued or pending patent applications. The technology covers real-time nerve sensing, mapping, physiological monitoring and feedb...